New tool for prognosis and choice of therapy for rheumatoid arthritis
(WorldNews Sweden)

In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints. In an article published today in the journal Annals of the Rheumatic Diseases, researchers at Uppsala University show that antibodies against the cartilage protein collagen II are associated with a good prognosis. `Analysing these antibodies, in combination with other relevant antibodies, could be used for predicting prognosis and choosing therapy for rheumatoid arthritis patients,` says Professor Johan Rönnelid who has led the study. Rheumatoid arthritis (RA) is an inflammatory...